ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA (ALL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA (ALL) trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA (ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radical transplant trial aims to replace diseased blood systems
Disease control Recruiting nowThis study is testing a specific type of stem cell transplant using donated umbilical cord blood to treat patients with serious blood cancers and disorders. The procedure involves high-dose chemotherapy and radiation to wipe out the patient's diseased bone marrow before infusing …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New CAR-T cell therapy aims to keep High-Risk leukemia at bay
Disease control Recruiting nowThis study is testing whether a personalized cell therapy called obecabtagene autoleucel (obe-cel) can help control a high-risk type of blood cancer (B-cell ALL) when given after the first round of treatment. Researchers will give the therapy to about 30 adults with this specific…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC